Sol-Gel Technologies Ltd.
Key Metrics
- Previous Close
- $52.83
- 52-Week Range
- $32.51 – $97.97
- Market Cap
- $174.70M
- P/E (TTM)
- —
- EPS (TTM)
- -5.22
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 4.08
- PEG Ratio
- —
- Return on Equity
- -46.53%
- Return on Assets
- -25.93%
- Gross Margin
- 0.00%
- Operating Margin
- -1224.72%
- Profit Margin
- 0.00%
- Current Ratio
- 7.12
- Debt/Equity
- 0.02
- Total Debt
- $805.00K
- Free Cash Flow
- —
- Revenue Growth
- -89.80%
- Earnings Growth
- —
- Enterprise Value
- $131.21M
Market Snapshot
About
Sol-Gel Technologies Ltd. is a dermatology company developing and commercializing topical therapies for skin diseases. The company utilizes its proprietary microencapsulation technology platform to create improved formulations of existing drugs and novel treatments. Sol-Gel markets products for acne, rosacea, and other dermatological conditions in the United States and internationally.